---
title: "ICU: QUELIMMUNE revenue surged 82% as adoption doubled, and adult AKI trial enrollment advanced on schedule"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295715528.md"
description: "QUELIMMUNE revenue grew 82% year-over-year in Q2 2026, with adoption doubling among top pediatric hospitals. NEUTRALIZE-AKI trial for adult AKI is progressing, with enrollment on track and regulatory milestones supported by FDA designations.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-12T22:04:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295715528.md)
  - [en](https://longbridge.com/en/news/295715528.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295715528.md)
generator: "portal-rs"
---

# ICU: QUELIMMUNE revenue surged 82% as adoption doubled, and adult AKI trial enrollment advanced on schedule

QUELIMMUNE revenue grew 82% year-over-year in Q2 2026, with adoption doubling among top pediatric hospitals. NEUTRALIZE-AKI trial for adult AKI is progressing, with enrollment on track and regulatory milestones supported by FDA designations.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ICU.US](https://longbridge.com/en/quote/ICU.US.md)
- [ICUI.US](https://longbridge.com/en/quote/ICUI.US.md)

## Related News & Research

- [Anthropic's AI fluency chief says the best AI users know when to do the work themselves](https://longbridge.com/en/news/298433044.md)
- [AXSM: AUVELITY's growth accelerates with new indications and strong pipeline progress, supported by solid financials](https://longbridge.com/en/news/298507457.md)
- [ICU Girişim Sermayesi Revamps Board, Strengthens Governance Oversight](https://longbridge.com/en/news/298065843.md)
- [ICU Medical VP, General Counsel Virginia Ruth Sanzone sells 4,856 shares for $821,190.99](https://longbridge.com/en/news/297964510.md)
- [ICU Girişim Sermayesi Details Diversified Venture Portfolio in Healthcare and Technology](https://longbridge.com/en/news/298353843.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**